No abstract

No abstract

Background: PKC is extremely important for a wide array of cellular processes. However, its inactivation is poorly understood. Results: FADD deficiency or phosphoryl-mimicking mutation (FADD-D) leads to accumulation of phosphorylated PKC and sustained signaling. Conclusion:The apoptotic adapter FADD is required for PKC dephosphorylation, degradation and signaling inactivation and may be regulated by its phosphorylation. Significance: FADD is critical for PKC dephosphorylation, stability, and signaling termination.

No abstract

Attenuated () strain VNP20009 has been employed as a powerful anticancer agent due to its selective accumulation in tumors for targeted therapy. has been demonstrated to constitute a delivery tool carrying antiangiogenic or proapoptotic genes that treat cancer. The hydrodynamic tail vein (HTV) injection of naked plasmid DNA has been developed as an effective gene delivery strategy, which has been successfully used. The aim of this study was to develop a combination therapy of VNP20009 and HTV injection of interleukin-21 (IL-21) expression plasmid to evaluate the antitumor potential on an experimental melanoma model. Consistent with previous results, single VNP20009 treatment was demonstrated to possess effective activities to suppress tumor growth and prolong animal survival. Moreover, HTV injection of IL-21 plasmid promoted the antitumor activities of VNP20009. The mice that were administered combined therapy exhibited smaller tumor sizes and longer survival time compared with those administered VNP20009 or IL-21 treatment alone. IL-21 induced more infiltrating natural killer (NK) and T cells to the tumor area. These findings indicated that in combination with IL-21 promotes antitumor immune responses, suggesting a novel strategy in the treatment of cancer.